Department of Neonatal Intensive Care Unit, The First Hospital of Tsinghua University, No. 6, Jiuxianqiao, Chaoyang District, Beijing, 100016, China.
BMC Pediatr. 2019 Apr 13;19(1):109. doi: 10.1186/s12887-019-1478-7.
Hypophosphatasia (HPP) is a rare hereditary disorder characterized by defective bone and tooth mineralization and deficiency of tissue non-specific alkaline phosphatase (TNAP) activity. The clinical presentation of HPP is highly variable, and the prognosis for the infantile form is poor.
This study reports a male infant diagnosed with lethal perinatal HPP. His gene analysis showed two heterozygous missense variants c.406C > T (p.R136C) and c.461C > T (p.A154V). The two mutations originated separately from his parents, consistent with autosomal recessive perinatal HPP, and the c.461C > T (p.A154V) was the novel mutation. Three-level structure model provide an explanation of the two mutated alleles correlating with the lethal phenotype of our patient. Results of SIFT, PolyPhen_2, and REVEL showed two mutations were pathogenic.
We demonstrated a case of perinatal lethal HPP caused by two heterozygous mutations, and one of which was novel. This finding will prove relevant for genetic counseling and perinatal gene testing for affected families.
低磷酸酯酶症(HPP)是一种罕见的遗传性疾病,其特征为骨骼和牙齿矿化不良以及组织非特异性碱性磷酸酶(TNAP)活性缺乏。HPP 的临床表现高度可变,婴儿型的预后较差。
本研究报告了一例诊断为致死性围生期 HPP 的男性婴儿。基因分析显示其存在两个杂合错义变异 c.406C>T(p.R136C)和 c.461C>T(p.A154V)。这两个突变分别来自于其父母,符合常染色体隐性遗传围生期 HPP,而 c.461C>T(p.A154V)是新的突变。三级结构模型解释了两个突变等位基因与我们患者致死表型的相关性。SIFT、PolyPhen_2 和 REVEL 的结果表明两个突变均具有致病性。
我们证明了一例由两个杂合突变引起的围生期致死性 HPP,其中一个是新的突变。这一发现将为受影响的家庭提供遗传咨询和围生期基因检测方面的依据。